<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">10935</article-id><article-id pub-id-type="doi">10.7554/eLife.10935</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Biochemistry and Chemical Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Structural Biology and Molecular Biophysics</subject></subj-group></article-categories><title-group><article-title>Inhibition by small-molecule ligands of formation of amyloid fibrils of an immunoglobulin light chain variable domain</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-40353"><name><surname>Brumshtein</surname><given-names>Boris</given-names></name><aff><institution content-type="dept">Department of Biological Chemistry, Department of Chemistry and Biochemistry</institution>, <institution>Howard Hughes Medical Institute, University of California, Los Angeles</institution>, <addr-line><named-content content-type="city">Los Angeles</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-41057"><name><surname>Esswein</surname><given-names>Shannon R</given-names></name><aff><institution content-type="dept">Department of Biological Chemistry, Department of Chemistry and Biochemistry</institution>, <institution>Howard Hughes Medical Institute, University of California, Los Angeles</institution>, <addr-line><named-content content-type="city">Los Angeles</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-41058"><name><surname>Salwinski</surname><given-names>Lukasz</given-names></name><aff><institution content-type="dept">Department of Biological Chemistry, Department of Chemistry and Biochemistry</institution>, <institution>Howard Hughes Medical Institute, University of California, Los Angeles</institution>, <addr-line><named-content content-type="city">Los Angeles</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-41059"><name><surname>Phillips</surname><given-names>Martin L</given-names></name><aff><institution content-type="dept">Department of Chemistry and Biochemistry</institution>, <institution>University of California, Los Angeles</institution>, <addr-line><named-content content-type="city">Los Angeles</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-41060"><name><surname>Ly</surname><given-names>Alan T</given-names></name><aff><institution content-type="dept">Department of Biological Chemistry, Department of Chemistry and Biochemistry</institution>, <institution>Howard Hughes Medical Institute, University of California, Los Angeles</institution>, <addr-line><named-content content-type="city">Los Angeles</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-41061"><name><surname>Cascio</surname><given-names>Duilio</given-names></name><aff><institution content-type="dept">Department of Biological Chemistry, Department of Chemistry and Biochemistry</institution>, <institution>Howard Hughes Medical Institute, University of California, Los Angeles</institution>, <addr-line><named-content content-type="city">Los Angeles</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-41062"><name><surname>Sawaya</surname><given-names>Michael R</given-names></name><aff><institution content-type="dept">Department of Biological Chemistry, Department of Chemistry and Biochemistry</institution>, <institution>Howard Hughes Medical Institute, University of California, Los Angeles</institution>, <addr-line><named-content content-type="city">Los Angeles</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-5056"><name><surname>Eisenberg</surname><given-names>David S</given-names></name><aff><institution content-type="dept">Department of Biological Chemistry, Department of Chemistry and Biochemistry</institution>, <institution>Howard Hughes Medical Institute, University of California, Los Angeles</institution>, <addr-line><named-content content-type="city">Los Angeles</named-content></addr-line>, <country>United States</country><email>david@mbi.ucla.edu</email></aff><xref ref-type="fn" rid="conf1"/></contrib></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1118"><name><surname>Kelly</surname><given-names>Jeffery W</given-names></name><role>Reviewing editor</role><aff><institution>Scripps Research Institute</institution>, <country>United States</country></aff></contrib></contrib-group><pub-date date-type="pub" publication-format="electronic"><day>18</day><month>11</month><year>2015</year></pub-date><volume>4</volume><elocation-id>e10935</elocation-id><history><date date-type="received"><day>18</day><month>08</month><year>2015</year></date><date date-type="accepted"><day>17</day><month>11</month><year>2015</year></date></history><permissions><copyright-statement>Â© 2015, Brumshtein et al</copyright-statement><copyright-year>2015</copyright-year><copyright-holder>Brumshtein et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><abstract><p>Overproduction of immunoglobulin light chains leads to systemic amyloidosis, a lethal disease characterized by the formation of amyloid fibrils in patients' tissues. Excess light chains are in equilibrium between dimers and less stable monomers which can undergo irreversible aggregation to the amyloid state. The dimers therefore must disassociate into monomers prior to forming amyloid fibrils. Here we identify ligands that inhibit amyloid formation by stabilizing the Mcg light chain variable domain dimer and shifting the equilibrium away from the amyloid-prone monomer.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd><italic>E. coli</italic></kwd></kwd-group></article-meta></front><back><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group></back></article>